| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.502 | 5.115 | 1.372 | 672 | - | - | - | - | - | - |
| Total Income - EUR | 12.502 | 5.115 | 1.372 | 672 | - | - | - | - | - | - |
| Total Expenses - EUR | 2.365 | 1.306 | 1.070 | 285 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 10.137 | 3.809 | 302 | 387 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 9.762 | 3.655 | 261 | 367 | - | - | - | - | - | - |
| Employees | 1 | 1 | 0 | 0 | - | - | - | - | - | - |
Check the financial reports for the company - Lotus Diagnostica-Imunologie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Current Assets | 27.409 | 23.171 | 21.790 | 21.091 | - | - | - | - | - | - |
| Inventories | 6.760 | 6.121 | 5.017 | 4.715 | - | - | - | - | - | - |
| Receivables | 8.667 | 5.707 | 5.659 | 5.478 | - | - | - | - | - | - |
| Cash | 11.982 | 11.343 | 11.113 | 10.898 | - | - | - | - | - | - |
| Shareholders Funds | 10.779 | 14.324 | 14.343 | 14.447 | - | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | - | - | - | - | - | - |
| Debts | 16.630 | 8.846 | 7.447 | 6.644 | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Lotus Diagnostica-Imunologie Srl